Investors

Find Psyched Wellness on These Exchanges

Psyched Wellness is led by a strong team of experts, and currently engaged in Pre-Clinical Trials of AME-1, its proprietary extract of Muscimol.

PSYC

Canada - CSE

5U9

Frankfurt

PSYCF

OTCQB

Capital Structure

Common Shares

Warrants

Options

RSU's

Fully Diluted

Issued and Outstanding

135,514,695

23,886,365

13,275,000

4,650,000

177,701,060

135,789,695

The company has identified a path to market and is on track to commence commercialization of AME-1 derived products for the first half of 2022.

Why Invest in Psyched Wellness?

FIRST TO MARKET

Psyched Wellness is the first company to bring the Amanita Muscaria to the market for human consumption in a standardized and safe product

PROVEN PRODUCT

The product is backed by science, patented, and trademarked to Psyched Wellness

RESPONSIBLE

We plan to have sustainable revenue from 2022 onwards

Company Overview

Psyched Wellness Ltd. Is a Canadian-based Life Sciences company focused on the research and development of a legal psychedelic mushroom called Amanita Muscaria. The company’s objective is to create premium mushroom-derived products that have the potential to become a leading North American brand in the emerging functional food category.

Sedar Profile